Prime Minister Olzhas Bektenov held a meeting of the Board of Directors of Kazakh Invest NC JSC, during which the current activities of the national company and plans for further work were considered, El.kz reports with reference to the press service of the Government.
Currently, Kazakh Invest supports 200 projects worth $27.3 billion with the creation of 68.8 thousand jobs. This year, more than 40 projects with foreign participation are expected to be launched.
One of the most significant is the enterprise for the production of medical equipment of the American company GE Healthcare in Astana. Within the framework of the project, the production of ultrasound and CT machines will be localized. This will make it possible not only to provide Kazakh hospitals, but also to further establish exports to other countries.
In addition, the company plans to organize educational programs to improve the skills of personnel in the republic's healthcare system.
Along with this, the Swiss company Roche will launch the production of anticancer drugs in Almaty with further prospects for export.
On behalf of the Prime Minister of the Republic of Kazakhstan, Kazakh Invest will focus on attracting investors to promising projects for deep processing of grain, production of in-demand types of plastics, localization of oil and gas equipment and other products with high added value.
"The Head of State has set the task of increasing the volume of the economy to $450 billion by 2029, during which it is necessary to attract at least $150 billion of foreign investment. In this regard, it is necessary to make every effort to find and attract large investors to our country. Non-standard solutions are needed," Olzhas Bektenov emphasized.